These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4113117)

  • 21. [Effect of rifampicin and ethambutol on Mycobacterium tuberculosis in vitro].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1973; 51(2):56-61. PubMed ID: 4203996
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 25. [Level of biologically active ethambutol and capreomycin in the blood serum of tuberculous patient].
    Zwolska-Opalańska Z
    Gruzlica; 1968 Mar; 36(3):283. PubMed ID: 5663108
    [No Abstract]   [Full Text] [Related]  

  • 26. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay.
    Yang Z; Durmaz R; Yang D; Gunal S; Zhang L; Foxman B; Sanic A; Marrs CF
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):201-8. PubMed ID: 16243477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differentiation between pathogenic and nonpathogenic mycobacteria of group II and group 3 by susceptibility to ethambutol].
    Tsukamura M
    Kekkaku; 1970 Aug; 45(8):237-40. PubMed ID: 5459676
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies of the criteria of chemoresistance to rifampicin and ethambutol].
    Bogdănescu V; Negulescu E; Ticău S; Vlădescu D
    Ftiziologia; 1973; 22(6):611-21. PubMed ID: 4204427
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 31. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 32. [Modern view points on the therapy of urogenital tuberculosis].
    Wehrheim W
    Z Urol Nephrol; 1973 Aug; 66(8):627-30. PubMed ID: 4129653
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures.
    Syre H; Valvatne H; Sandven P; Grewal HM
    J Antimicrob Chemother; 2006 May; 57(5):987-91. PubMed ID: 16524896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitivity of atypic mycobacteria to rifampicin and ethambutol].
    Makarevitch NM
    G Ital Chemioter; 1972; 19(2):23-5. PubMed ID: 4666006
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
    Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
    J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations.
    Perdigão J; Macedo R; Ribeiro A; Brum L; Portugal I
    Int J Antimicrob Agents; 2009 Apr; 33(4):334-8. PubMed ID: 19097862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ethambutol concentration in the blood of patients with pulmonary tuberculosis].
    Ginsburg TS; Bialik IB
    Probl Tuberk; 1971; 49(7):32-5. PubMed ID: 5005809
    [No Abstract]   [Full Text] [Related]  

  • 39. [A study of the composition of rifampicin- and ethambutol-resistant variants of wild strains of M. tuberculosis, cultivated on Loewenstein-Jensen medium].
    Le Lirzin M; Djurovic V
    Ann Inst Pasteur (Paris); 1971 Apr; 120(4):531-48. PubMed ID: 4998275
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bacteriostatic effect of ethambutol on tubercle bacilli sensitive or resistant to other antitubercular drugs. A modification of the vertical diffusion method for determination of biologically active ethambutol].
    Strupczewska-Januszowa H; Grzymska L; Zwolińska G
    Gruzlica; 1969 Jul; 37(7):623-8. PubMed ID: 4981782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.